Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 2.68 AUD 0.37%
Market Cap: AU$3.4B

Wall Street
Price Targets

MSB Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MSB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MSB is 3.61 AUD with a low forecast of 3.14 AUD and a high forecast of 4.2 AUD.

Lowest
Price Target
3.14 AUD
17% Upside
Average
Price Target
3.61 AUD
35% Upside
Highest
Price Target
4.2 AUD
57% Upside
Mesoblast Ltd Competitors:
Price Targets
NNOX
Nano-X Imaging Ltd
170% Upside
ZNTL
Zentalis Pharmaceuticals Inc
102% Upside

Revenue
Forecast

-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MSB's stock price target?
Price Target
3.61 AUD

According to Wall Street analysts, the average 1-year price target for MSB is 3.61 AUD with a low forecast of 3.14 AUD and a high forecast of 4.2 AUD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
177%

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

Back to Top